Studies of the Natural History and Pathogenesis of Autoimmune/Connective Tissue Diseases
NCT00341679
Autoimmune Diseases, Autoimmune/Connective Tissue Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT Number: NCT02881450
Knowledge of the descriptive epidemiology of MIs is very limited. The main objective of this study is to determine the prevalence of inflammatory myopathies in Alsace at the 1st January 2012 with "capture-recapture" design using several independent sources of case identification.
Looking for future studies?
Notify MeAll sexes
Observational
Inflammatory myopathies (MIs) are a group of muscle diseases with a significant heterogeneity, clinical, immunological and prognosis.
The old classifications, still currently used, highlight this heterogeneity. Therefore Troyanov and coll. and Hoogendijk and coll. have each recently proposed a classification based on clinical and serological - and immuno- histological examination.
The pathogenesis and prognosis of MIs is very different depending on the entity in question.
Knowledge of the descriptive epidemiology of MIs is very limited. In fact no epidemiological work using criteria consensual classification is actually started.
We propose an epidemiological study of MIs. The main objective of the study is to determine the prevalence of MIs in Alsace at 1stJanuary 2012 by means of a "capture- recapture" study using several independent sources of case identification. The secondary objectives of the study are:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Prevalence of idiopathic inflammatory myopathies in Alsace at 1st January 2012
University Hospital, Strasbourg, France
Other
Prevalence of Inflammatory Myopathies in Alsace
Acronym: PREMIA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00341679
Autoimmune Diseases, Autoimmune/Connective Tissue Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT05523167
Active Idiopathic Inflammatory Myopathy, Antisynthetase Syndrome
Phoenix, Arizona, United States
View Trial DetailsNCT01432613
Connective Tissue Diseases, Dermatomyositis
Amiens, France
View Trial DetailsNCT05027152
Behavior, Connective Tissue Diseases
Vitória, Espírito Santo, Brazil
View Trial Details